Abstract
The activity of PD 117596-2, a novel quinolone, was compared to that of other quinolones, ceftazidime, imipenem and gentamicin. PD 117596-2 inhibited mostEnterobacteriaceae at concentrations <0.25 µg/ml, being equal or superior in activity to ciprofloxacin and 2- to 4-fold more active than ofloxacin. It inhibited ceftazidime-resistantEnterobacter spp.,Citrobacter spp. andSerratia marcescens. The MIC90 forPseudomonas aeruginosa, including strains with imipenem MICs of 8 µg/ml and gentamicin MICs > 16 µg/ml, was 0.25 µg/ml. PD 117596-2 was more active than ciprofloxacin againstPseudomonas cepacia andPseudomonas maltophilia, and it inhibitedNeisseria gonorrhoeae andHaemophilus influenzae at < 0.03 µg/ml. PD 117596-2 inhibited staphylococci at 0.5 µg/ml, being 2-fold superior to other quinolones, and with an MIC of 0.25 µg/ml was more active against group A, B, C and G streptococci andStreptococcus pneumoniae. MICs forBacteroides spp. were 2 µg/ml compared to 8–32 µg/ml for other agents. The frequency of spontaneous resistance was low (< 10−10). Differences in MICs and MBCs were within one dilution, and there was a minimal effect of inoculum size. Although PD 117596-2 was less active at pH 5.5, MICs were < 0.5 µg/ml.
Similar content being viewed by others
References
Cornett, J. B., Wentland, M. P. Quinolone antibacterial agents. In: Bailey, D. N. (ed.): Annual Reports in Medicinal Chemistry. Volume 21. Academic Press, New York, 1986, p. 139–148.
Neu, H. C. The quinolones: prospects. In: Andriole V. T. (ed.): The quinolones. Academic Press, London, 1988, p. 235–254.
Chin, N. X., Brittain, D. C., Neu, H. C. In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrobial Agents and Chemotherapy 1986, 29: 675–680.
Hirschhorn, L., Neu, H. C. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620. Antimicrobial Agents and Chemotherapy 1986, 30: 143–146.
Chin, N. X., Neu, H. C. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. American Journal of Medicine 1987, 82: 58–62.
Wise, R., Ashby, J. P., Andrews, J. M. In vitro activity of PD 127,391, an enhanced-spectrum quinolone. Antimicrobial Agents and Chemotherapy 1988, 32: 1251–1256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neu, H.C., Chin, N.X. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone. Eur. J. Clin. Microbiol. Infect. Dis. 8, 644–650 (1989). https://doi.org/10.1007/BF01968149
Issue Date:
DOI: https://doi.org/10.1007/BF01968149